Skip to main content
Publication date
2018 01 20
Authors
Anand, SS Bosch, J Eikelboom, JW Connolly, SJ Diaz, R Widimsky, P Aboyans, V Alings, M Kakkar, AK Keltai, K Maggioni, AP Lewis, BS Stork, S Zhu, J Lopez-Jaramillo, P O'Donnell, M Commerford, PJ Vinereanu, D Pogosova, N Ryden, L Fox, KAA Bhatt, DL Misselwitz, F Varigos, JD Vanassche, T Avezum, AA Chen, E Branch, K Leong, DP Bangdiwala, SI Hart, RG Yusuf, S
Group authors
COMPASS Investigators
Author KI Usernames
Ryden, L|larryd
Pubmed ID
29132880
Journal
Lancet (London, England)
Doctype
Article
KI Connection
Låg
Mesh SV
Acetylsalicylsyra Amputation Blödning Dosrelaterad effekt av läkemedel Dubbelblindmetod Faktor Xa-hämmare Halsartärsjukdomar Hjärtinfarkt Hjärt-kärlsjukdomar Incidens Kombinationsbehandling Kvinnlig Läkemedelstillförselschema Manlig Medelålders personer Människa Nedre extremitet Perifer artärsjukdom Rivaroxaban Sjuklighet Slaganfall Trombocytaggregationshämmare Äldre
Mesh EN
Amputation Aspirin Cardiovascular Diseases Carotid Artery Diseases Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Drug Therapy, Combination Factor Xa Inhibitors Hemorrhage Incidence Lower Extremity Morbidity Myocardial Infarction Peripheral Arterial Disease Platelet Aggregation Inhibitors Rivaroxaban Stroke
First date
2018-02-18T22:31:20.026Z